Loading...
Complete response of advanced hepatocellular carcinoma to sorafenib: another case and a comprehensive review
Since sorafenib was introduced in 2007 for treating advanced hepatocellular carcinoma (HCC), 15 patients have achieved a complete response (CR) in advanced HCC. However, only four of these reports can be regarded as real CRs involving adequate assessments including imaging, serum tumor markers, and...
Na minha lista:
| Udgivet i: | Clin Mol Hepatol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Association for the Study of the Liver
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5760007/ https://ncbi.nlm.nih.gov/pubmed/28633200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0070 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|